Neoplasms, Basal Cell - 16 Studies Found
| Completed |
: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial :
|
| Completed |
: Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma : Pilomatrixoma : 2008-07-11 |
| Completed |
: Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture :
: 2006-02-15 : Device: standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut) |
| Not yet recruiting |
: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma : Basal Cell Carcinoma : 2016-12-26 : Drug: Vismodegib 1 capsule (150 mg vismodegib) taken once daily for a maximum of 12 weeks. |
| Recruiting |
: Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions : Metastatic Basal Cell Carcinoma : 2016-04-24 |
| Recruiting |
: Topical Itraconazole in Treating Patients With Basal Cell Cancer : Skin Basal Cell Carcinoma : 2016-03-31 :
|
| Not yet recruiting |
: Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer : Skin Basal Cell Carcinoma : 2016-03-01 :
|
| Recruiting |
: Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer : Skin Basal Cell Carcinoma : 2016-02-12 :
|
| Recruiting |
: Observational Study to Determine the Effectiveness and Safety of Vismodegib in Patients With Locally Advanced Basal Cell Carcinoma (laBCC) : Locally Advanced Basal Cell Carcinoma : 2016-02-02 : Drug: Vismodegib Dosing of Vismodegib in accordance with local clinical practice and local labeling |
| Active, not recruiting |
: Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) : Basal Cell Carcinoma : 2016-01-20 : Drug: ERIVEDGE Other Name: VISMODEGIB |